1.
Randomized, Double-Masked Trial of Netarsudil 0.02% Ophthalmic Solution for Prevention of Corticosteroid-Induced Ocular Hypertension.
Price Marianne O, Feng Matthew T, Price Francis W
Am J OphthalmolOct 20209 citationsRandomized Controlled Trial
Netarsudil did not significantly reduce steroid-induced IOP elevation after corneal transplantation, offering no clear prophylactic benefit in this setting, despite some irritation side effects.